Book a demo
Strategy & Corporate DevelopmentEvent: September 2, 2026

Cooper Consumer Health signed a licensing agreement with Esserre to introduce Armolipid Cholesterol Plus, a new-generation formula developed to support proactive cholesterol management.

Published

Signal category

Strategy & Corporate Development

Quote

announcing the signing of a licensing agreement with Esserre to introduce Armolipid® Cholesterol Plus

Cooper Consumer Health team

Company

Cooper Consumer Health

Empowering Healthier Living 💛

Industry
Pharmaceutical Manufacturing
Location
Paris, FR
Company size
1,338 employees

Cooper Consumer Health has grown into Europe's largest independent pure-play selfcare platform, serving millions of people. We develops, manufactures and distributes a broad portfolio of self-care brands and serves more than 100,000 pharmacies and drugstores across Europe and beyond. With an extensive commercial footprint, proven operational capabilities and dedicated local teams, Cooper Consumer Health help people take charge of people's health with effective, trusted solutions; guided by the belief that brighter health leads to a stronger you.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.